Raumedic to Build a Development Center and Production Plant in the U.S.
Raumedic AG, Helmbrechts, Germany, system supplier for polymer-based components and systems in the medical technology and pharmaceutical industry, is investing USD 27.1 million to construct a new production center in Mills River, NC/USA.
Raumedic Inc., has been distributing tubing, molded parts and catheters, which until now had been produced exclusively in Germany, to North America for over ten years. With the decision to build the US headquarters with development center and clean room production in North Carolina, Raumedic provides its North American customers a local service center. "Our new production center in the US will combine the strengths of our German and American engineering. This will give rise to high-quality polymer extrusion, injection molded and assembled products for our North American customers. Henderson County in northwestern North Carolina offers us experienced and skilled employees and the ideal business environment for our investments," says Martin Bayer, CEO of Raumedic AG.
Raumedic will invest USD 27.1 million by 2022. 10.6 million of this will go towards the construction of the new building, including a state-of-the-art clean room production facility. A two-story administration and production building with a total area of 60,000 ft² (5,600 m²) will be built in the open countryside. Up to 22,000 ft² (2,000 m²) of this will be available for production. Raumedic Inc. will start there in January of 2016 with more than 50 employees and increase this number gradually to over 100. This will create long-term jobs for specialists in the areas of clean room production, engineering, research and development, laboratory work, logistics, marketing and sales and administration.
Would you like to subscribe to our Newsletters on plastics technology and profit from the latest information?
Looking for a new challenge? Check out our jobs market!
Patents encourage innovation: Stay on the ball with the latest innovations in the plastics industry in our patents section.